To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.
Retrieved from the GovBot source 9/23/2026, 6:51:32 AM (UTC). Viewing this record does not change stored data.
At a glance
- Bill number
- HR 679
- Status
- Not provided
- Latest recorded action
- Referred to the House Committee on Energy and Commerce.
Summary
Not provided in this source record.
Recorded activity
Newest date first. Actions with the same timestamp retain source order.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Retrieval & source record
- Search index built (UTC)
- 2026-09-07T10:23:11.520Z
- Dataset
- govbot-data/usa-legislation
- Retrieved (UTC)
- 2026-09-23T06:51:32.793Z
- Live source branch
- main (mutable; checksum identifies the retrieved record)
- Search index revision
b5b4a6d28d2dd595bb5724470458ffceaf19bcb7- Original record
- View GovBot metadata JSON (opens in a new tab)
- Record SHA-256
577f27288b8b2138d302610d7d6625aca7b7a9e6167dae2c3050d9302982bba7